Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RepRegen CE marks tissue regeneration product

This article was originally published in Clinica

Executive Summary

RepRegen has CE marked StronBone, a biomaterial designed to repair and regenerate hard tissue, for sale in the EU. The product is a bioactive glass containing strontium, which boosts performance of bioceramics for bone repair, RepRegen says. The London, UK firm, formerly known as BioCeramic Therapeutics, said that the approval would allow it to accelerate discussions with potential strategic partners about its hard tissue product platform in general and StronBone in particular. RepRegen's other hard tissue repair products are geared towards the orthopaedic market, including some to address trauma and spinal defects, and craniomaxillofacial applications.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095083

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel